• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Immunotherapy-induced Addison's disease: A rare, persistent and potentially lethal side-effect.

作者信息

Hescot S, Haissaguerre M, Pautier P, Kuhn E, Schlumberger M, Berdelou A

机构信息

Department of Medical Oncology, Institut Curie, Paris, France; Department of Endocrine Oncology, Gustave Roussy, Villejuif, France.

Department of Endocrinology, CHU Bordeaux, Bordeaux, France.

出版信息

Eur J Cancer. 2018 Jul;97:57-58. doi: 10.1016/j.ejca.2018.04.001. Epub 2018 May 3.

DOI:10.1016/j.ejca.2018.04.001
PMID:29731229
Abstract
摘要

相似文献

1
Immunotherapy-induced Addison's disease: A rare, persistent and potentially lethal side-effect.免疫疗法诱发的艾迪生病：一种罕见、持续且可能致命的副作用。
Eur J Cancer. 2018 Jul;97:57-58. doi: 10.1016/j.ejca.2018.04.001. Epub 2018 May 3.
2
Rare case of delayed onset colitis due to immunotherapy for malignant melanoma.恶性黑色素瘤免疫治疗导致迟发性结肠炎的罕见病例。
ANZ J Surg. 2019 Oct;89(10):E472-E473. doi: 10.1111/ans.14768. Epub 2018 Aug 22.
3
Sarcoidosis-Like Granulomatous Reaction Associated With Pembrolizumab Immunotherapy.与帕博利珠单抗免疫治疗相关的结节病样肉芽肿反应
Arch Bronconeumol (Engl Ed). 2018 Nov;54(11):592-593. doi: 10.1016/j.arbres.2018.04.010. Epub 2018 May 22.
4
[Toxic epidermal necrolysis due to anti-PD1 treatment with fatal outcome].[抗程序性死亡蛋白1治疗导致中毒性表皮坏死松解症并致死]
Ann Dermatol Venereol. 2017 Jan;144(1):65-66. doi: 10.1016/j.annder.2016.11.012. Epub 2016 Dec 20.
5
Tisotumab vedotin (Tivdak) for cervical cancer.
Med Lett Drugs Ther. 2024 Jun 24;66(1705):e109-e110. doi: 10.58347/tml.2024.1705g.
6
A patient with pembrolizumab-induced fatal polymyositis.
Eur J Cancer. 2018 Mar;91:180-182. doi: 10.1016/j.ejca.2017.12.019. Epub 2018 Jan 10.
7
Gas Bubbles: A Persistent Problem with Immunotherapy.气泡：免疫疗法中一个长期存在的问题。
Dig Dis Sci. 2021 Aug;66(8):2542-2544. doi: 10.1007/s10620-020-06768-4. Epub 2021 Jan 6.
8
Pembrolizumab-associated inflammatory myopathy.帕博利珠单抗相关的炎性肌病。
Rheumatology (Oxford). 2018 Feb 1;57(2):397-398. doi: 10.1093/rheumatology/kex346.
9
Severe ophthalmoplegia and myocarditis following the administration of pembrolizumab.帕博利珠单抗给药后出现严重眼肌麻痹和心肌炎。
Eur J Cancer. 2018 Mar;91:171-173. doi: 10.1016/j.ejca.2017.11.026. Epub 2017 Dec 26.
10
Pembrolizumab tunes up chemotherapy in cervical cancer.帕博利珠单抗增强宫颈癌化疗效果。
Nat Rev Clin Oncol. 2021 Dec;18(12):747. doi: 10.1038/s41571-021-00570-5.

引用本文的文献

1
Mild Primary Adrenal Insufficiency During Treatment With Lenvatinib and Pembrolizumab: A Report of 3 Patients.乐伐替尼和帕博利珠单抗治疗期间的轻度原发性肾上腺功能不全：3例报告
JCEM Case Rep. 2025 Jun 19;3(8):luaf123. doi: 10.1210/jcemcr/luaf123. eCollection 2025 Aug.
2
Management, biomarkers and prognosis in people developing endocrinopathies associated with immune checkpoint inhibitors.免疫检查点抑制剂相关内分泌病患者的管理、生物标志物与预后
Nat Rev Endocrinol. 2025 May;21(5):289-300. doi: 10.1038/s41574-024-01077-6. Epub 2025 Jan 9.
3
Challenges in autoimmune polyendocrine syndrome type 2 with the full triad induced by anti-programmed cell death 1: a case report and review of the literature.
抗程序性细胞死亡蛋白 1 诱导的完全三联征自身免疫性多内分泌腺综合征 2 型的挑战：病例报告及文献复习。
Front Immunol. 2024 Apr 18;15:1366335. doi: 10.3389/fimmu.2024.1366335. eCollection 2024.
4
Endocrine Side Effects in Patients Treated with Immune Checkpoint Inhibitors: A Narrative Review.接受免疫检查点抑制剂治疗患者的内分泌副作用：一项叙述性综述
J Clin Med. 2023 Aug 7;12(15):5161. doi: 10.3390/jcm12155161.
5
The Uncharted Landscape of Rare Endocrine Immune-Related Adverse Events.罕见内分泌免疫相关不良事件的未知领域
Cancers (Basel). 2023 Mar 28;15(7):2016. doi: 10.3390/cancers15072016.
6
Endocrine-related adverse conditions in patients receiving immune checkpoint inhibition: an ESE clinical practice guideline.接受免疫检查点抑制治疗患者的内分泌相关不良事件：ESE 临床实践指南。
Eur J Endocrinol. 2022 Oct 25;187(6):G1-G21. doi: 10.1530/EJE-22-0689. Print 2022 Dec 1.
7
Insights Into the Host Contribution of Endocrine Associated Immune-Related Adverse Events to Immune Checkpoint Inhibition Therapy.内分泌相关免疫相关不良事件对免疫检查点抑制疗法宿主贡献的见解
Front Oncol. 2022 Jul 14;12:894015. doi: 10.3389/fonc.2022.894015. eCollection 2022.
8
The Changing Face of Drug-induced Adrenal Insufficiency in the Food and Drug Administration Adverse Event Reporting System.《食品和药物管理局不良事件报告系统中药物性肾上腺功能不全的变化面貌》。
J Clin Endocrinol Metab. 2022 Jul 14;107(8):e3107-e3114. doi: 10.1210/clinem/dgac359.
9
Polyendocrine Autoimmunity and Diabetic Ketoacidosis Following Anti-PD-1 and Interferon α.抗 PD-1 和干扰素 α 治疗后发生的多内分泌腺自身免疫和糖尿病酮症酸中毒。
Pediatrics. 2022 Apr 1;149(4). doi: 10.1542/peds.2021-053363.
10
Editorial: From Chronic Inflammation to Cancer: How Far Can Immunotherapy Go?社论：从慢性炎症到癌症：免疫疗法能走多远？
Front Pharmacol. 2022 Jan 12;12:838917. doi: 10.3389/fphar.2021.838917. eCollection 2021.